Mints are differentially phosphorylated by Src family of kinases in vitro. HEK293T cells were co-transfected with plasmids expressing Src family kinases and putative substrates. A–B, Representative immunoblots of cell lysates expressing constitutively active c-Src, kinase-deficient c-Src (Src inactive), Fyn, Yes, or Lyn kinases with Disabled protein Dab1, Mint1, Mint2 or Mint3 and blotted with a phospho-tyrosine specific antibody 4G10. C, HEK293T cells were transfected with Mint1 or Mint2 in the presence of active or inactive Src kinase or transfected with only a single plasmid. Phospho-tyrosine proteins were immunoprecipitated using phospho-tyrosine specific antibody 4G10. Precipitated proteins were analyzed by immunoblotting with Mint1 (lanes 1–5) or Mint2 (lanes 6–10) antibody. D, Phospho-tyrosine proteins were immunoprecipitated using phospho-tyrosine specific antibody 4G10 from primary neuronal cultures. Precipitated proteins were analyzed by immunoblotting with Mint1 or Mint2 antibody. E, Representative immunoblots of cell lysates expressing constitutively active c-Src, Fyn, Yes, or Lyn kinases with Mint1, APPswe and wild-type APP and blotted with 4G10. F, Postulated tyrosine phosphorylation sites for Mint2 by Src kinase at amino acid positions 86, 110 and 193 in rat Mint2 was identified. Below are recombinant GST-Mint2 truncated fusion proteins that encompass the Mint2 protein in overlapping fragments: N-terminal region (GST-Mint2-N; residues 1–399), PTB domain (GST-Mint2-PTB; residues 363–546) and two tandem PDZ domains (GST-Mint2-C; residues 546–750). G, In vitro phosphorylation assay combining purified Src with GST-Mint2 fusion proteins described in F. Coomassie brilliant blue (CBB) staining indicates equal amount of GST protein. H, Representative immunoblots of lysates from HEK293T cells co-transfected with Src kinase and Mint2 wild type (Mint2-WT, lanes 1 and 4), or Mint2 phosphomutants where tyrosines 86, 110 and 193 were mutated to glutamic acid (Mint2-Y3E, lanes 2 and 5) or phenylalanine (Mint2-Y3F, lanes 3 and 6). I, Relative phosphotyrosine immunoreactivity are quantified by normalizing mean pixel intensity of the 4G10 signal to that of Tubulin and expressed as percent of control. (** p<0.01 and *** p<0.005).